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EDITORIAL
Intrarenal antibiotic distribution in health and disease
Despite the controversy that exists concerning the
exact incidence of pyelonephritis [1], the data of
Stamey, Govan and Palmer [2], Reeves and Brumfitt
[3], Fairley, Bond and Brown [4, 5] and Ronald,
Cutler and Turck [6], identifying the site of infection
in urinary tract infections, suggest that 25 to 5O% of
patients with urinary tract infections may have renal
parenchymal infection. The frequency of recurrent
urinary tract infections and the fact that a substantial
number of all patients entering hemodialysis and renal
transplantation programs may have chronic pyelone-
phritis as their primary form of renal disease serve to
document the need for continuing critical evaluation
of the management and antibiotic therapy of
pyelonephritis.
Although it is reasonable to suspect that tissue anti-
biotic concentrations may provide an important
potential determinant of response to treatment, such
data are still somewhat limited. Several different
techniques have been used to identify renal tissue drug
concentrations; however, each of them possesses
distinct limitations which complicate translation of
the derived results into solid clinico-therapeutic
information.
In pyelonephritis there are unique features of the
intrarenal location of infection and the intrarenal
distribution of antibiotics that make review of these
two phenomena a potentially productive exercise. The
site of initial bacterial seeding in acute pyelonephritis
and the zone of continued bacterial activity in chronic
active pyelonephritis is predominantly the medullary-
papillary region of the kidney [2, 7—11]. Although the
reasons for this curious susceptibility of the inner
zones of the kidney to bacterial infection are in-
completely understood, some clear-cut relationships
have been identified between both the structural
integrity and the functional activity of the kidney and
its susceptibility to bacterial infection. It appears that
the low blood flow into the medulla and papilla,
which is an integral part of the operation of the
countercurrent multiplier system [12], may result in
decreased delivery of leukocytes, complement and
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antibody into the inner zones of the kidney, while the
reduced tissue oxygen tension and hypertonicity in
the latter zones also inhibit leukocyte function and
thereby increase tissue susceptibility to infection. The
anticomplementary effect of free ammonia in the renal
medulla and papilla [8] also enhances the susceptibility
of these tissues to bacterial infection.
Recent work from our laboratory indicates that
remarkable variation exists among the different anti-
biotics with respect to the medullary-papillary con-
centrations achieved during their administration. In
addition, the intrarenal distribution pattern of these
compounds is often significantly altered as the state of
renal physiologic activity is changed, or by the
presence of disease in the renal parenchyma. These
findings suggest that we should attempt to properly
evaluate the potential therapeutic importance of
correlating the pathophysiology and antibiotic man-
agement of pyelonephritis. To do so we need to ask
two fundamental questions: 1) What are the deter-
minants of renal tissue drug concentration in the
presence of normal kidney function? 2) How does the
presence, form and extent of renal disease influence
tissue drug accumulation?
An answer to either of these questions must of
necessity include information pertinent to a) the
physiochemical nature of the drug such as its degree
of serum and renal tissue protein binding, its molecu-
lar size and configuration, its ionization charac-
teristics and degree of lipid solubility; b) the extent to
which the compound may participate in active trans-
tubular secretory processes, pH-dependent non-ionic
diffusion processes or countercurrent exchange pro-
cesses; c) the identification of measured tissue drug
levels as being representative of bioactive antibiotic
or metabolically degraded drug; d) the free bioactive
drug concentrations at the critical anatomical site, or
distribution volume, in terms of antibacterial activity;
e) the influence of various forms and extent of renal
disease on intrarenal parenchymal drug concentration;
and f) the significance of drug dosage in influencing
kidney tissue drug accumulation in either healthy or
diseased kidneys.
For many antibiotics comprehensive data as listed
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above are often unavailable, or at best the information
is fragmentary. However, from a practical point of
view we can coalesce and briefly review data derived
using four investigative techniques that are particularly
suited to identifying intrarenal drug pharmacokinetics
in health and disease: 1) analysis of renal lymph, 2)
autoradiography and fluorescence distribution in renal
tissues, 3) stop-flow studies and 4) analysis of renal
tissue homogenates.
Renal lymph analysis. Since lymph fluid represents a
derivative of interstitial fluid, analysis of antibiotic
concentrations in renal lymph represents a method of
defining antibiotic concentrations in the interstitial
fluid of the kidney [13—18]. In such studies it is
assumed that cortical drug concentrations are reflected
in the lymph obtained from capsular lymphatics and
that hilar lymph reflects interstitial concentrations of
drug in the medulla and papilla. However, recent
studies of lymph formation in the kidney [19, 20]
indicate that it is not possible to separately identify
lymph produced in the interstitium of the renal
medulla-papilla and that of the cortex.
Autoradiography and fluorescence distribution in the
kidney. Autoradiographic techniques have been used
to evaluate renal tissue concentrations of strepto-
mycin and tetracycline by Andre [211 and by Currie,
Little and McDonald [22] to study cephaloridine and
nitrofurantoin. Similar techniques were used by
Romas and Clark [23] to evaluate tetracycline con-
centrations in healthy and pyelonephritic rat kidneys.
These studies have proved of some value in identifying
the intrarenal distribution and cellular location of the
above-named drugs; however, quantitative data
cannot easily be derived from the investigations, and
the state of hydration and urinary pH of the experi-
mental animals were not clearly identified. Most
importantly, from the therapeutic point of view, such
studies only identify a tissue concentration of radio-
activity which could represent both microbiologically
active antibiotic and nonbioactive radioactive meta-
bolites of the drug.
Helander and Bottinger used the fluorescent pro-
perties of the tetracycline analogues under ultraviolet
light to monitor the tissue distribution of those com-
pounds in the kidneys of mice [24]. Subsequently,
Malek et al [25] described the distribution of tetra-
cycline analogues in experimentally diseased rabbit
kidneys and demonstrated that tetracycline fluores-
cence was particularly prolonged in areas of ischemic
renal parenchyma. The drawback to the use of
fluorescent techniques is similar to that noted for
radioautography, since micrObiologically active, com-
plexed and inactive tetracycline degradation products
cannot be separately identified within the tissues.
Stop-flow studies. Stop-flow analysis may be useful
in identifying the site of antibiotic secretion or
reabsorption within the nephron. However, only a
small number of antibiotics have been investigated by
such means. In the case of nitrofurantoin (pKa 7.2)
Woodruff, Malvin and Thompson [26] used stop-flow
studies to demonstrate that the drug was influenced
distally in the nephron by urinary pH, with the
greatest degree of distal tubular reabsorption occurring
when the urine was acid and highest urine concen-
trations of the drug being apparent when the urine was
alkaline. Cephaloridine transport by dog and rabbit
nephrons was investigated by Child and Dodds [27].
They interpreted their results as showing that cepha-
loridine was not secreted by the proximal tubule in
such species and thereby raised some important
questions concerning the nephrotoxicity of the drug,
since its presumed nephrotoxicity was postulated as
being related to proximal tubular secretion. The sub-
sequent studies of Tune [28] clearly identified the
importance of proximal tubular secretion of cepha-
loridine in rabbit kidney, particularly with respect to
its nephrotoxicity, and his important studies will be
reviewed in more detail later. These contradictory
studies of the renal handling of cephaloridine identify
the care with which stop-flow results must be inter-
preted, since in such studies the measured urinary
concentration of drug may represent the net result of
unidirectional or bidirectional active secretion in the
proximal tubule with or without distal tubular
reabsorption.
Intrarenal ampicillin (pKa1 2.7; pKa2 7.5) pharma-
cokinetics have been studied in our laboratory [29] by
stop-flow analytic techniques and will be discussed
later.
Analysis of renal tissue homogenates. Most pharma-
cologic screening of antimicrobial compounds defines
drug concentrations in homogenates of whole kidney,
and only in a small number of investigations have
tissue concentrations of antimicrobials been measured
in the different zones of the kidney.
The intrarenal distribution of several drugs in the
sulfonamide class have been studied by direct analysis
of renal tissue homogenates for sulfonamide activity.
The studies of Schlegel and Burden [30] and O'Dell,
Jarrell and Schlegel [31] in the dog kidney have shown
that although the state of hydration could markedly
change the concentrations of sulfurazole or sul-
fisoxazole in the urine, the renal tissue levels of drug
were only slightly increased in the hydropenic state.
Silva, Macia and Torretti [32] found similar results for
sulfisoxazole in hydropenic rat kidneys, and Silva and
Mudge [33] demonstrated that, in dog kidney,
sulfasymazine medullary-papillary concentrations were
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only slightly increased during antidiuresis, but that
despite a pH-dependent renal clearance distal non-
ionic diffusion did not influence renal tissue con-
centrations of the drug.
In our laboratories this technique of antibiotic
analysis in renal tissue homogenates has served to
define the intrarenal distribution characteristics of
several of the commonly used antibiotics and the
influence of the state of hydration and urinary pH
upon the latter gradient patterns [34—39].
Intraluminal location of drug versus interstitial and
intracellular location. Total antibiotic concentrations
measured in renal tissue homogenates represents a
sum of contributions from blood, interstitial fluid,
intracellular fluid and intraluminal filtrate or urine.
No exact data are available to define the anatomic
volume of renal tissue occupied by intraluminal
contents in either the cortex, medulla or papilla of the
kidney. We have previously, however, made some
estimate of the volume of papilla occupied by intra-
luminal contents during hydropenia by comparing
distribution volumes of different substances [35].
From such data and from our unpublished studies
characterizing the intrarenal distribution charac-
teristics of inulin and p-aminohippuric acid it appears
that approximately 1.4 to 2.0% of the hydropenic
normal papilla is occupied by intraluminal urine.
In the case of the commonly used antibiotics it is
also possible to define a theoretic volume of drug
distribution in the hydropenic papilla. When the latter
volume is greater than the anatomic confines of the
intraluminal space, the excess of the antibiotic
distribution space must represent the quantity of drug
distributed in the interstitial (including vasa recta
blood) and intracellular spaces of the hydropenic
papilla. For example, in the case of carbenicillin (37)
the drug's theoretic papillary volume of distribution
may be calculated as follows:
Carbenicillin conc/mlhyopeflicpapj1la X 100
— 4 2 + 0 50Carbenicillin conc/ml,ne . /
Comparable figures for ampicillin, inulin and
p-aminohippuric acid are 1.4 to 2.0%. If this lower
distribution volume range is taken as that most closely
approximating the anatomic intraluminal volume,
then it may be estimated that one-half to two-thirds of
the measured carbenicillin in the hydropenic papilla is
distributed outside the lumina of those portions of
nephron included in the papilla. It thus appears that
papillary concentrations of carbenicillin exceed that
of plasma by as much as 12 to 15 times. Although this
value of carbenicillin concentration within the
interstitial-intracellular areas of the normal hydro-
penic papilla represents an approximation, it none-
theless identifies an order of magnitude for compart-
mental distribution of the drug in the renal papilla
and affords a useful means of interpreting the results
of intrarenal drug distribution characteristics when
papillary tissue homogenates of drug are measured.
These data also suggest that consideration of this
type may be of major importance in determining the
usefulness or effectiveness of different antibiotics,
particularly with respect to correlating bacterial drug
sensitivity data identifying the minimal inhibitory
concentrations of the compound and the drug levels
achievable in different zones of the kidney at specific
dosage regimens.
Factors influencing intrarenal antibiotic distribution
in normal kidneys. It is not practical to review here all
of the determinants influencing drug accumulation and
distribution in the healthy kidney. However, it is
worthwhile to take a broad view of the influence of the
state of hydration, the significance of antibiotic
binding to renal tissue and the role of urinary pH in
determining the intrarenal distribution characteristics
of antibiotics.
Influence of the state of hydration. Data on anti-
biotic concentrations in normal kidneys have been
obtained in experimental animal models, in particular
the dog. Fig. 1 summarizes the influence of the state
of hydration upon the intrarenal gradient patterns of
several of the more commonly used antibiotics as
determined in 186 healthy dog kidneys by techniques
previously described from this laboratory [35]. In
these studies the hydrated and hydropenic states
represented, respectively, urine flow rates of 2 to 4
ml/min/kidney (urine osmolality 200 to 300 mOsm/kg)
and 0.1 to 0.05 mI/mm/kidney (urine osmolality
1000 to 2000 mOsm/kg). The urine/serum ratios in
hydropenia were greater than 500 in the case of
penicillin G and carbenicillin; 200 to 300 for ampicillin,
gentamicin, kanamycin and cephalothin; 50 to 150 for
oxytetracycline and sulfisoxazole; and in the case of
doxycycline the ratio was 15. None of these urine/
serum ratios have been corrected for serum protein
binding. They clearly indicate, when compared to the
renal tissue/serum concentration ratios, that urinary
concentrations of an antibiotic do not necessarily
directly reflect concomitant drug concentrations in the
medulla-papilla of the kidney, and thereby resolve a
point of earlier controversy [2]. In the hydrated state
the urine/serum ratios ranged between 5 and 15 for
all antibiotics except oxytetracycline and doxycycline,
where the ratios were 2 and 1, respectively.
For the penicillins and cephalothin, a significant
increase in cortico-papillary gradient pattern is noted
in the hydropenic state with drug concentrations
following the sequence penicillin G > carbenicillin>
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ampicillin =cephalothin. When the volumes of distri-
bution of these compounds in the hydropenic papilla
are measured as described earlier, the increase in
antibiotic concentration in the interstitial-intracellular
region of the papilla over that measured concomitantly
in the serum is ten to 15-fold in the case of penicillin U
and carbenicillin; three to six-fold for cephalothin and
for ampicillin with alkaline urine; and one and one-
half to three-fold for the remaining drugs in Fig. 1.
It is apparent that in the hydrated state (Fig. 1) the
increase in cortico-papillary gradient noted for the
penicillins and cephalothin during hydropenia is
completely ablated. This "wash out" of antibiotics
from the renal tissues is also associated with markedly
decreased urinary drug concentrations. The other
remaining antibiotics in Fig. 1 do not exhibit signifi-
cant increases in cortico-papillary distribution pattern
during hydropenia, although an overall increase in
tissue drug concentration during hydropenia is of note
for kanamycin, oxytetracycline and sulfisoxazole.
Renal tissue drug binding. A most important
additional finding was the observation of a 20-fold
increase in cortical gentamicin concentrations over
those noted in the serum. The renal lymph studies of
Chisholm, Calnan and Waterworth [16, 17], however,
demonstrated that gentamicin concentrations in the
latter fluid were similar to concomitant serum values.
Since gentamicin accumulation in the renal cortex may
bear some relationship to its potential nephrotoxicity,
this observation was explored further. In the cortex
we identified a 70 to 85% binding of the drug to
cellular proteins. This reconciles our results with the
renal lymph studies of Chisholm et al [16, 17], since
the fraction of gentamicin found in the renal cortex
could not be detected by renal lymph analysis. In
addition our preliminary data have demonstrated, in
half of the dogs studied, that quinine, a blocker of the
proximal tubular organic base secretory system [40],
significantly reduced cortical gentamicin accumulation.
One possible explanation for the high cortical
gentamicin concentration is the diffusion or transport
of this highly charged basic aminoglycoside anti-
biotic into the proximal tubular cells, with intra-
cellular binding of the drug to proteins of opposite
charge. By comparison it is noteworthy that con-
centrations of the nephrotoxic cephalosporin cepha-
loridine in rabbit renal cortex as measured in the
studies of Tune [28] were twelve times those noted in
the serum. The latter drug is a derivative of an
organic acid, and the administration of competitive
blockers of the organic acid proximal tubular secretory
system not only reduced the renal cortical concentra-
tions of cephaloridine but also protected the kidney
against the nephrotoxic effects of the compound. It is
also evident (Fig. I) that hydropenic cortical concen-
trations of the aminoglycoside kanamycin are some ten
times those noted in serum. These data suggest that
additional investigations of renal tissue binding of
nephrotoxic drugs may further contribute to an under-
standing of the mechanisms of their nephrotoxicity.
Influence of urinary pH. Since most antibiotics are
either weak acids or bases, it might be expected that
many of them would be influenced in both renal
clearance and renal tissue concentration by inducing
changes in urinary pH through the mediation of the
physiologic phenomenon of non-ionic diffusion [40].
Woodruff et al [26] demonstrated by stop-flow analysis
that furadantin (pKa 7.2) undergoes distal non-ionic
diffusion with higher clearance values associated with
alkaline urine. Unfortunately, concomitant tissue
analyses were not performed in their studies. Studies
from our laboratory demonstrated a pH-dependent
clearance for the organic acids, penicillin U and
cephalothin [34] and identified an influence of
urinary pH [29] on the intrarenal distribution charac-
teristics of ampicillin (pKaj 2.7; pKa2 7.5). Alkaline
urine significantly increased medullary-papillary con-
centrations of ampicillin. Stop-flow analysis revealed
that during production of alkaline urine there was an
enhancement of proximal tubular secretion of the
compound, such as has been demonstrated for p-
aminohippuric acid during systemic alkalosis [41], and
that as ampicillin reached the distal portion of the
O Hydropenia
• Hydration
Fig. 1. Intrarenal gradient patterns of many commonly used anti-
biotics in 186 healthy dog kidneys during variation in the state of
hydration. Concomitant urine/serum ratios are included in the
text.
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nephron it underwent greater non-ionic back diffusion
into interstitium of the medulla and papilla than was
seen during production of acid urine. Thus, an intra-
renal recycling of the drug occurred during the
production of alkaline urine.
Sulfisoxazole (pKa 4.9) renal tissue concentrations
are not much influenced by the state of hydration
(Fig. 1), but relative concentration of the drug in the
medulla and papilla is enhanced during the production
of acid urine. Doxycycline (isoelectric point at pH 5.5)
demonstrates significant pH-dependent urinary clear-
ance values with enhanced excretion in alkaline urine.
The renal tissue concentrations are not, however,
influenced by such changes in urinary pH [39].
Antibiotic concentrations in diseased human kidneys.
Gradient patterns of several antibiotics in the diseased
renal tissues of patients with end-stage kidney disease
have been studied as such individuals were undergoing
bilateral nephrectomy in preparation for renal
transplantation. The patients received the usual
parenteral therapeutic doses of an antibiotic two to
four hours prior to nephrectomy. Table 1 summarizes
data derived from these studies in 37 diseased human
kidneys and contrasts the results with comparable
figures for normal hydropenic dog kidneys. Since
adequate urinary specimens could not be obtained at
nephrectomy, urine/plasma drug data at similar
dosage schedules were collected one week prior to
nephrectomy for comparison with the renal tissue data.
These urine/plasma ratios (± SEM) were gentamicin
3.1 1.3, carbenicillin 11.3 ampicillin 3.5±0.8,
cephalothin 1.0 0.2 and doxycycline 0.6 0.08.
With the exception of doxycycline, a significant
reduction of antibiotic concentration was produced in
each zone of the diseased kidney tissue when com-
pared with healthy kidneys. The tissue drug concen-
trations tend to be the same in each zone of the
kidney and are in general approximately one-half to
two-thirds the concomitant serum value. In the case
of doxycycline tissue, values remained some twofold
higher than concomitantly measured serum levels. It
would therefore appear that serum antibiotic levels
represent the best guide to coexistent drug levels in
diseased renal tissue. It is again important to em-
phasize that no data are available to correlate solidly
these drug concentration results in severely diseased
human kidneys with either short- or long-term
therapeutic results. The drug concentration data
taken on their own perhaps suggest that in the
management of patients with diseased and infected
kidney tissues it may be more therapeutically desirable
to select a compound with the least systemic toxicity
and the most effective tissue accumulation. This
fundamentally important question deserves much
further attention and evaluation so that solid clinico-
therapeutic correlates can be developed.
Two additional studies of the concentrations of
carbenicillin and naladixic acid in diseased human
kidneys are of note. Ivan, Arr and Foldi [42] reported
on the carbenicillin concentrations achieved in whole
renal tissue at a time when unilateral nephrectomy was
undertaken for the management of pyelonephritis or
renal tumor, although preoperative renal function and
state of hydration were not reported. The renal tissue/
plasma ratio of carbenicillin was 3.2 SEM 0.3 at the
time of nephrectomy. Penetrance of the drug into
tumorous tissue, analyzed separately, was markedly
reduced. Jameson [43] studied nalidixic acid concen-
tration in diseased renal tissue obtained from patients
undergoing elective nephrectomy for pyelonephritis.
Mean renal tissue drug concentrations were two and
one-half times those noted in serum, but the pre-
operative renal function was not recorded.
The data presented in Fig. 1 and Table 1 represent
opposite ends of a spectrum of antibiotic concentra-
tion in healthy and diseased kidneys. Further in-
formation will be necessary to characterize the drug
concentrations in renal tissue that may be achieved at
Table 1. Renal tissue/serum ratios for healthy hydropenic dog (56 studies) and diseased human kidneys (37 studies)
Cortex Medulla Papilla
Healthy Diseased Healthy Diseased Healthy Diseased
Gentamicin 20±2.4 0.9±0.08 4±0.6 0.9±0.09 6±0.3 0.8±0.08
Kanamycin 10±0.7 0.5±0.05 6±0.5 0.5±0.07 8.5±1.0 0.5±0.08
Carbenicillin 3±0,3 0.6±0.1 7±0.7 0.7±0.05 18±1.3 0.7±0.06
Ampicillin 2.7±0.4 0.5±0.07 2.6±0.5 0.7±0.3 5.7±0.9 0.5±0.07
Cephalothin 1.9±0.2 0.6±0.3 2.6±0.3 0.6±0.2 5.7±0.6 0.6±0.2
Doxycycline 3±0.3 2.0±0.2 2.0±0.2 2.0±0.3 2.0±0.1 2.0±0.2
Mean SEM.
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intermediate degrees of renal impairment. An appro-
priate model of experimental pyelonephritis could
provide the means of obtaining such results.
Summary. The major points of potential therapeutic
importance deriving from the study of intrarenal
antibiotic distribution characteristics may be sum-
marized as follows: 1) It is difficult to predict the
intrarenal distribution characteristics of an antibiotic
since factors other than plasma concentration and
antibiotic clearance by the kidney appear to exert
significant influences upon accumulation within
different regions of the kidney. 2) The hydropenic
state enhances the cortico-papillary gradient pattern of
several antibiotics, particularly the penicillins, cepha-
lothin and to a lesser extent the sulfonamides. 3)
Induction of the hydrated state serves to reduce
markedly the urinary concentrations of all antibiotics;
in addition the penicillins, cephalothin, kanamycin,
oxytetracycline and the sulfonamides are reduced in or
"washed out" from the renal parenchyma during
water diuresis. 4) Alkaline urine facilitates an increase
of ampicillin concentrations in the renal medulla and
papilla; acid urine increases the distribution of sul-
fisoxazole in the latter zones. Several antibiotics
demonstrate pH-dependent renal clearance. 5) Con-
trary to previously held concepts, the urinary concen-
centration of an antibiotic does not necessarily reflect
the coexistent drug level in the renal medulla or
papilla. 6) The presence of severe disease in the renal
parenchyma significantly changes the intrarenal
pharmacokinetics of antibiotics and is associated with
reduced tissue concentrations of all drugs with the
exception of doxycycline. 7) No clinical data are as yet
available to correlate drug distribution in healthy or
diseased renal tissue with long term therapeutic
results. Such studies merit careful attention.
Intrarenal tissue drug distribution studies may
ultimately provide a better understanding of the
factors of importance in selecting the appropriate
drug for treatment of renal infections and may contri-
bute to a better understanding of the mechanisms
underlying antibiotic nephrotoxicity. Data available
at present are incomplete and often fragmentary, but
further systematic study of the factors influencing
intrarenal drug concentrations promises information
of both therapeutic and toxicologic value.
Andrew Whelton
W. Gordon Walker
Baltimore, Maryland
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